Huihui Chen

Title: Innovations of Huihui Chen in Pharmaceutical Research

Introduction

Huihui Chen is a notable inventor based in Tianjin, China, recognized for his contributions to pharmaceutical research. He has been instrumental in developing innovative solutions that enhance the efficacy and stability of pharmaceutical compounds. With a total of three patents to his name, his work is paving the way for advancements in drug formulation and delivery.

Latest Patents

Huihui Chen's latest patents include a crystal form of urate transporter 1 inhibitor and a preparation method and use thereof. This invention provides a crystal form characterized by a stable state of appearance, which significantly improves the purity and storage stability of the compound, making it suitable as a pharmaceutical raw material. Another notable patent is a method for preparing a URAT1 inhibitor, specifically 2-((5-bromo-4-((4-bromonaphthalen-1-yl)methyl)-4H-1,2,4-triazol-3-yl)thio) acetic acid. This method is distinguished by its low cost, ease of handling, and applicability to industrialization, thus offering a practical approach to drug development.

Career Highlights

Huihui Chen is affiliated with the Tianjin Institute of Pharmaceutical Research Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work is characterized by a commitment to improving drug formulations and enhancing therapeutic outcomes for patients.

Collaborations

Huihui Chen collaborates with esteemed colleagues, including Guilong Zhao and Changying Liu, who contribute to the research and development efforts at the institute. Their combined expertise fosters a collaborative environment that drives innovation in pharmaceutical research.

Conclusion

Huihui Chen's contributions to pharmaceutical research through his innovative patents highlight his role as a significant inventor in the field. His work not only advances drug formulation but also enhances the overall quality of pharmaceutical products.